Physician profile
Ryan Michael Fields
NPI 1265845176
$1,796.47
in general payments reported to CMS, 2019-2025
21 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $11.05 · 2021: $311 · 2022: $125 · 2023: $239 · 2024: $249 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $871.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $418.52 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $167.04 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $166.35 | 2019-2024 | |
| Pfizer INC. | $134.00 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.00 | 2025 | Xifaxan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $111.92 | 2019 | |
| Stryker Corporation | $103.08 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Allergan, INC. | $100.95 | 2019 | |
| Abiomed | $76.87 | 2024-2025 | Impella |
| Abbvie INC. | $68.86 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $67.69 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.40 | 2019-2024 | Jardiance |
| Recor Medical INC | $53.11 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Gilead Sciences, INC. | $29.22 | 2024 | |
| Atricure, INC. | $18.77 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18.38 | 2025 | Collagenase Santyl |
| Inspire Medical Systems, INC. | $17.16 | 2025 | Inspire |
| Abbott Laboratories | $16.44 | 2023 | Mitraclip |
| Bioxcel Therapeutics, INC. | $15.85 | 2023 | Igalmi |
| Otsuka America Pharmaceutical, INC. | $13.83 | 2019 | |
| Melinta Therapeutics, LLC | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.